Context Therapeutics (NASDAQ:CNTX) Coverage Initiated at William Blair
Equities research analysts at William Blair began coverage on shares of Context Therapeutics (NASDAQ:CNTX – Get Free Report) in a research report issued on Monday, MarketBeat reports. The brokerage set an “outperform” rating on the stock. A number of other equities research analysts have also recently issued reports on CNTX. Citizens Jmp raised shares of […]
Equities research analysts at William Blair began coverage on shares of Context Therapeutics (NASDAQ:CNTX – Get Free Report) in a research report issued on Monday, MarketBeat reports. The brokerage set an “outperform” rating on the stock. A number of other equities research analysts have also recently issued reports on CNTX. Citizens Jmp raised shares of […]
